Graeme Smith Email

SVP, Nonclinical Development . Skyhawk Therapeutics

Current Roles

Employees:
71
Revenue:
$5.5M
About
Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that correct RNA expression. Our founders are leading experts in small molecule therapeutics development for RNA-based disease. Our first drug candidates are targeted towards cancers and neurological conditions. The company is based in Waltham, Massachusetts. For more information, please visit: www.skyhawktx.com.
Skyhawk Therapeutics Address
35 Gatehouse Dr
Waltham, MA
United States
Skyhawk Therapeutics Email

Past Companies

Skyhawk TherapeuticsSenior Vice President, Nonclinical Development
Vertex PharmaceuticalsVice President, Global Head of Preclinical Safety Assessment & Bioanalysis
Vertex PharmaceuticalsSr. Director, Head of Preclinical Safety Assessment

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.